Waters Corporation (WAT) continues to hold its place as a significant player in the Research Tools & Consumables market, with activities worth noting in Q1. Its executives demonstrated their accountability by visiting Wall Street earlier in the year. The corporation has seen a boost in its business in India due to the demand for weight-loss drugs. Despite a slump in trading volume, their financial strength isn't overlooked, and they are keeping up with the healthcare sector.
Waters expanded its biological analysis portfolio by acquiring
Halo Labs. Its annual earnings have been released, providing more insight into the company's financial standing. An increase in Price Target by BofA added to the company's appeal.
Notably, Waters opened a state-of-the-art Precision Manufacturing Facility in Longbridge, UK, and their integration of Multi-Angle Light Scattering detectors shows commitment to improving quality control. They continue to prove lucrative as an investment with increasing sales and the acquisition of the light scattering instrument and software leader, Wyatt Technology.
Waters Corporation remained committed to research and innovation, setting new benchmarks and introducing new products such as the ACQUITY PREMIER Liquid Chromatography Solution.
Waters Corp WAT News Analytics from Wed, 18 Sep 2019 07:00:00 GMT to Fri, 04 Jul 2025 03:32:00 GMT -
Rating 5
- Innovation 8
- Information 7
- Rumor -5
